RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Basgen to Rats

This is a "connection" page, showing publications John Basgen has written about Rats.
Connection Strength

0.135
  1. Bai XY, Basgen JM. Podocyte number in the maturing rat kidney. Am J Nephrol. 2011; 33(1):91-6.
    View in: PubMed
    Score: 0.055
  2. Zhou Y, Castonguay P, Sidhom EH, Clark AR, Dvela-Levitt M, Kim S, Sieber J, Wieder N, Jung JY, Andreeva S, Reichardt J, Dubois F, Hoffmann SC, Basgen JM, Montesinos MS, Weins A, Johnson AC, Lander ES, Garrett MR, Hopkins CR, Greka A. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models. Science. 2017 12 08; 358(6368):1332-1336.
    View in: PubMed
    Score: 0.022
  3. Basgen JM, Nevins TE, Michael AF. Quantitation of antigen in tissue by immunofluorescence image analysis. J Immunol Methods. 1989 Nov 13; 124(1):77-83.
    View in: PubMed
    Score: 0.013
  4. Nicholas SB, Mauer M, Basgen JM, Aguiniga E, Chon Y. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol. 2004 Sep-Oct; 24(5):549-56.
    View in: PubMed
    Score: 0.009
  5. Nevins TE, Gaston T, Basgen JM. Quantitative indexes of aminonucleoside-induced nephrotic syndrome. Am J Pathol. 1984 Oct; 117(1):30-6.
    View in: PubMed
    Score: 0.009
  6. Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 2002 Mar; 61(3):939-50.
    View in: PubMed
    Score: 0.008
  7. Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature. 1996 Jul 18; 382(6588):275-8.
    View in: PubMed
    Score: 0.005
  8. Li YM, Steffes M, Donnelly T, Liu C, Fuh H, Basgen J, Bucala R, Vlassara H. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci U S A. 1996 Apr 30; 93(9):3902-7.
    View in: PubMed
    Score: 0.005
  9. Steffes MW, Vernier RL, Brown DM, Basgen JM, Mauer SM. Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation. Diabetologia. 1982 Oct; 23(4):347-53.
    View in: PubMed
    Score: 0.002
  10. Houser MT, Scheinman JI, Basgen J, Steffes MW, Michael AF. Preservation of mesangium and immunohistochemically defined antigens in glomerular basement membrane isolated by detergent extraction. J Clin Invest. 1982 May; 69(5):1169-75.
    View in: PubMed
    Score: 0.002
  11. Steffes MW, Leffert JD, Basgen JM, Brown DM, Mauer SM. Epithelia cell foot process width in intact and uninephrectomized diabetic and nondiabetic rats. Lab Invest. 1980 Sep; 43(3):225-30.
    View in: PubMed
    Score: 0.002
  12. Steffes MW, Brown DM, Basgen JM, Mauer SM. Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes. 1980 Jul; 29(7):509-15.
    View in: PubMed
    Score: 0.002
  13. Steffes MW, Brown DM, Basgen JM, Matas AJ, Mauer SM. Glomerular basement membrane thickness following islet transplantation in the diabetic rat. Lab Invest. 1979 Aug; 41(2):116-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support